As listed in Table 3, the difference in the ages between patients with and without EML4-ALK is significant (p < 0.02 by Chi-square test), suggesting an early-onset of NSCLC in EML4-ALK positive patients. The gene discussed is ALK; the disease is non-small cell lung carcinoma.